Court Order Prevents Distribution, Use of ST500 Prawn Treatment09 October 2012
UK - The prawn industry is being urged to take heed of the terms of a recent Court Order granted in favour of Xyrex Ltd prohibiting both Shellfish Treatments Ltd and its director Ruary Mcgregor from manufacturing, distributing or selling the prawn treatment ST500.
Interim interdicts have been served on behalf of Xyrex Ltd on the basis that Shellfish Treatments Ltd and company director Ruary McGregor have breached the Intellectual Property rights of Xyrex Ltd in respect of its Prawnfresh and Prawnfresh Plus products.
The interim interdicts prevent both Shellfish Treatments Ltd and Ruary McGregor as well as any employees or agents of them from either “manufacturing, distributing or selling” ST500.
In the event of this order being breached by any party, Xyrex Ltd has advised they will take immediate steps to protect its business and seek to recover any loss or damage sustained.
This is the second time an interdict has had to be served on a company in which Ruary McGregor has been involved – the first instance was in November 2010 for the Shrimp Treat product, which was also deemed to be a direct copy of Prawnfresh Plus. This interdict is still in force.
John Davis, managing director of Xyrex Ltd, said: “A scientific analysis has clearly shown that ST500 is a copy of Prawnfresh Plus, which breached our Intellectual Property rights for the product. We have had no option other than to instruct our lawyers Morisons LLP to obtain and serve these latest interdicts because the integrity of Prawnfresh Plus brand and its high standing and reputation in the marketplace were being put in jeopardy.
“Xyrex is committed to servicing and supporting the requirements of the prawn industry with Prawnfresh and Prawnfresh Plus. These products are manufactured to the ISO 9001 standard and are fully traceable. This ensures that they are high quality, safe and proven products that prevent the onset of melanosis in harvested prawns.”
TheFishSite News Desk